Pharmaceutical Industry Information Portal

HomeRegulatory News

Regulatory News

Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia

Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia from September 1 and will expire on...

FDA approves Sanofi’s Dupixent for widespread use in the United States

Sanofi won expanded U.S. approval for its best-selling Dupixent injection to treat an allergic inflammation of the esophagus, the Food and Drug Administration said...

U.S.FDA lifts ban on COVAXIN Covid-19 vaccine candidate study

Ocugen, Inc., a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals, and vaccines, May 23th announced that the U.S. Food...

MicroGEM’s PCR test, which gives results in 27 minutes, received EUA approval from FDA

MicroGEM has been granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) for the MicroGEM Sal6830 SARS-CoV-2 Saliva Test, which...

Sun Pharma shares up 4% after FDA approves mesalamine capsules

Sun Pharmaceutical Industries Limited, announced that it has received final approval from US FDA for its Abbreviated New Drug Application (ANDA) for generic Mesalamine...

Lupin receives two FDA approvals and share price jumps

Global pharma major Lupin Ltd, May 06th, announced that it has received approval from the United States Food and Drug Administration (FDA) for its...
spot_img

Expert Articles

spot_img